Summary
Thermo Fisher Scientific Inc. reported revenues of $2.48 billion for the second quarter ended June 27, 2009, a decrease of 8% compared to the prior year's quarter. This decline was attributed to a general economic downturn impacting customer demand, particularly for equipment sales. Despite the revenue challenges, the company demonstrated resilience in managing costs, with operating income decreasing by 22% year-over-year. Restructuring and other costs increased due to economic responses, but productivity improvements helped offset some of the revenue decline. The company's balance sheet shows a solid cash position of $1.42 billion, providing liquidity. However, long-term obligations remain significant at $2.02 billion. The company's strategy continues to focus on augmenting internal growth with strategic acquisitions, such as the Biolab acquisition in April 2009, which expands its geographic reach. Despite a challenging macroeconomic environment, Thermo Fisher maintains a positive outlook on its ability to meet future cash requirements through operating cash flow and available credit.
Key Highlights
- 1Total revenues for the second quarter of 2009 were $2.48 billion, down 8% year-over-year, primarily due to decreased demand from the global economic downturn.
- 2Operating income decreased by 22% to $259 million in Q2 2009, reflecting lower profitability from reduced revenues, partly offset by cost controls and productivity improvements.
- 3The company reported $1.42 billion in cash and cash equivalents as of June 27, 2009, indicating strong liquidity.
- 4Acquisitions remain a key part of the company's strategy, with the acquisition of Biolab in April 2009 noted as expanding geographic reach.
- 5Restructuring and other costs increased significantly in Q2 2009 ($13 million vs. $5 million in Q2 2008), largely due to actions taken in response to the economic downturn.
- 6Effective tax rate decreased to 10.9% in Q2 2009 from 19.6% in Q2 2008, attributed to reduced earnings in higher tax jurisdictions.
- 7The company generated $734 million in cash flow from operations for the first six months of 2009, an increase from $590 million in the prior year's period, driven by improved working capital management.